| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/06/2005 | EP0944310B1 Stabilized ascorbyl compositions |
| 04/06/2005 | EP0933366B1 5-phenyl-3-pyridazinone derivatives and drug compositions containing the same |
| 04/06/2005 | EP0920426B9 New thiazole derivatives with phosphodiesterase-inhibiting effect |
| 04/06/2005 | EP0912521B1 Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
| 04/06/2005 | EP0824594B1 Improved methods for transfecting t cells |
| 04/06/2005 | EP0802790B1 Transdermal therapeutic system for dispensing (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole or one of its pharmaceutically acceptable salts |
| 04/06/2005 | EP0801561B1 Composition and methods for transdermal delivery of acid-labile drugs |
| 04/06/2005 | EP0748219B1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/06/2005 | CN2689944Y Chitosan medical film wound plaster |
| 04/06/2005 | CN1605027A Methods and compositions for treatment of central nervous system disorders |
| 04/06/2005 | CN1604968A Methods to treat diabetes and related conditions based on polymorphisms in the TCF-1 gene |
| 04/06/2005 | CN1604963A Method for the in vitro synthesis of short double stranded RNAs |
| 04/06/2005 | CN1604906A Antisense antiviral agent and method for treating ssRNA viral infection |
| 04/06/2005 | CN1604904A Phosphonic acid compounds as inhibitors of serine proteases |
| 04/06/2005 | CN1604901A Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/06/2005 | CN1604900A 6-aminomorphinane derivatives, method for production and use thereof |
| 04/06/2005 | CN1604898A 3-heteroaryl-3, 5-dihydro-4-oxo-4h-pyridazino[4, 5-b]indole-1-carboxamide derivatives, their preparation, their intermediates and pharmaceutical compositions containing the compounds |
| 04/06/2005 | CN1604897A 7-amino-benzothiazole derivatives as adenosine receptor ligands |
| 04/06/2005 | CN1604893A Cyclic amine compounds |
| 04/06/2005 | CN1604892A Prodrugs to d-prolines |
| 04/06/2005 | CN1604890A 取代的环己烷衍生物 Substituted cyclohexane derivatives |
| 04/06/2005 | CN1604803A Combination of cytochome p450 dependent protease inhibitors |
| 04/06/2005 | CN1604800A Drug delivery system for conscious sedation |
| 04/06/2005 | CN1604795A Combination motif immune stimulatory oligonucleotides with improved activity |
| 04/06/2005 | CN1604793A Methods of treatment and formulations of cephalosporin |
| 04/06/2005 | CN1604790A Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi) |
| 04/06/2005 | CN1604787A Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (TFPI) |
| 04/06/2005 | CN1604784A Heparin-containing ophthalmic agent |
| 04/06/2005 | CN1604783A Drug for treating a fibrotic disease through rna interfence |
| 04/06/2005 | CN1604782A Stabilized brivudine topical formulations |
| 04/06/2005 | CN1604781A Use of desoxypeganine for treating clinical depression |
| 04/06/2005 | CN1604780A Use of rosuvastatin in pre demented states |
| 04/06/2005 | CN1604779A Novel methods of treating local fungal and bacterial infections |
| 04/06/2005 | CN1604778A Cis-imidazolines |
| 04/06/2005 | CN1604777A Method of treatment |
| 04/06/2005 | CN1604776A 4-4-alkoxy-3-hydroxyphenyl-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 04/06/2005 | CN1604775A Modulation of ocular growth and myopia by GABA drugs |
| 04/06/2005 | CN1604774A 血管生成抑制剂 An angiogenesis inhibitor |
| 04/06/2005 | CN1604773A Treatment of faecal incontinence and other conditions with 1r, 2s-methoxamine |
| 04/06/2005 | CN1604772A Transdermal transport of compounds |
| 04/06/2005 | CN1604770A Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs |
| 04/06/2005 | CN1604741A Adhesion inhibition of moulds |
| 04/06/2005 | CN1603356A Biodegradable copolymer and high molecular supermolecule composite containing same |
| 04/06/2005 | CN1603342A Caspase-8 interacting proteins |
| 04/06/2005 | CN1603331A 9-{2-[bis(pivaloyloxymethoxy) phosphorylmethoxyl]ethyl} adenine glucuronate and its preparation process |
| 04/06/2005 | CN1603327A New process for the preparation of vinyl pyrrolidinone cephalosporine derivatives |
| 04/06/2005 | CN1603318A Genistein derivatives and their preparation process and use |
| 04/06/2005 | CN1603314A Pyrazolobenzodiazepines as CDK2 inhibitors |
| 04/06/2005 | CN1603307A Cyanoacrylate derivatives and their preparation method and biological activity |
| 04/06/2005 | CN1603291A Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 04/06/2005 | CN1602960A Mixture for preventing and treating metabolic syndrome like cerebrovascular and cardiovascular disease |
| 04/06/2005 | CN1602939A Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases and preparing process thereof |
| 04/06/2005 | CN1602891A Glucosidase oral liquid |
| 04/06/2005 | CN1602890A Preparation for brown algae amylose complexing agent capable of improving chlamys farreri immunity and feeding method thereof |
| 04/06/2005 | CN1602889A Preparation method of clindamycin phosphate powder injection |
| 04/06/2005 | CN1602888A Azithromycin enteric casing preparation and its preparing process |
| 04/06/2005 | CN1602887A Erythromycin ethylsuccinate for injection and its preparation process and application |
| 04/06/2005 | CN1602886A Pharmaceutical compositions and its application |
| 04/06/2005 | CN1602885A Meridian dredging capsule containing panax pseudo-ginseng tri-alcohol saponin and its preparation process |
| 04/06/2005 | CN1602884A Blood vessel dredging capsule containing panax pseudo-ginseng tri-alclhol saponin and its preparation process |
| 04/06/2005 | CN1602883A Pharmaceutical compositions containing ginsenoside, safflor yellow and its preparation and application |
| 04/06/2005 | CN1602882A Orally disintegrating tablet of gypenosides and its preparation process |
| 04/06/2005 | CN1602881A Diabetin for injection and its preparation process |
| 04/06/2005 | CN1602880A Method for inhibitting bone resorption |
| 04/06/2005 | CN1602879A Method for inhibitting bone resorption |
| 04/06/2005 | CN1602878A Preparation process of polyene phosphatidylcholine injection |
| 04/06/2005 | CN1602877A Pharmaceutical composition for treating somatization disorder and its preparation process |
| 04/06/2005 | CN1602876A Dimethoxanate hydrochloride dripping pills and its preparation method |
| 04/06/2005 | CN1602875A MolsidominE dripping pills and its preparation process |
| 04/06/2005 | CN1602874A Sustained release preparation of propylthiouracil and its preparation method |
| 04/06/2005 | CN1602873A Sustained release preparation of glipizide/metformin hydrochloride and its preparation method |
| 04/06/2005 | CN1602872A Antituberculosis pharmaceutical composition |
| 04/06/2005 | CN1602871A Preparation process of antifungal itraconazole containing freeze dried powder injection and transfusion |
| 04/06/2005 | CN1602870A Dripping pills of bucinnazine hydrochloride and its preparation |
| 04/06/2005 | CN1602869A Dripping pills of eprazinone hydrochloride and its preparation |
| 04/06/2005 | CN1602868A Dripping pills of ketotifen fumarate and its preparation method |
| 04/06/2005 | CN1602867A Soft capsule preparation of donepezi hydrochloride and its preparation method |
| 04/06/2005 | CN1602866A Dripping pills of tripelennamine hydrochloride and its preparation method |
| 04/06/2005 | CN1602865A Fat emulsion injection of bulleyaconitine A and its manufacturing method |
| 04/06/2005 | CN1602864A Vaginal effervescent tablet of fibrauretine and its preparation method |
| 04/06/2005 | CN1602863A Dripping pills of furazabol and its preparation method |
| 04/06/2005 | CN1602862A Application of leflunomide in the preparation process of anti SARS virus medicine |
| 04/06/2005 | CN1602861A Buccal tablet for treating oral anaerobe infection disease and its manufacturing method |
| 04/06/2005 | CN1602860A Dripping pills of clemastine fumarate and its preparation method |
| 04/06/2005 | CN1602859A Dripping pills of methoxsalen and its preparation method |
| 04/06/2005 | CN1602858A Arteannuin preparation for treating gynecopathy |
| 04/06/2005 | CN1602857A Orally disintegrating tablet of safflor yellow and its preparation process |
| 04/06/2005 | CN1602856A Calcium L-Threonate and soy bean isoflavone containing combination |
| 04/06/2005 | CN1602855A Application of forsythin in the process for preparing adiposis treating oral medicine and healthy food |
| 04/06/2005 | CN1602854A Taxel preparation for intravenous injection |
| 04/06/2005 | CN1602853A Active constituent of traditional Chinese medicine capable of inhibiting SARS coronavirus infection and its bioactivity measuring method |
| 04/06/2005 | CN1602852A Sodium houttuyfonate injection and its preparation method |
| 04/06/2005 | CN1602851A Dripping pills of benactyzine hydrochloride and its preparation |
| 04/06/2005 | CN1602850A Nú¿2ú®-L-alanyl-L-glutamine injection and its preparation method |
| 04/06/2005 | CN1602849A Propranolol hydrochloride drop pills and its preparation method |
| 04/06/2005 | CN1602848A Ambroxol hydrochloride drop pills and its preparation method |
| 04/06/2005 | CN1602847A Bupicomide hydrochloride drop pills and its preparation method |
| 04/06/2005 | CN1602846A Oxyfenamate hydrochloride drop pills and its preparation method |
| 04/06/2005 | CN1602845A Fenfluramine hydrochloride drop pills and its preparation method |
| 04/06/2005 | CN1602844A Mitoxantrone or mitoxantrone hydrochloride liposome injection and its preparing process |